查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1998337

週边血管医疗设备市场：2026-2032年全球市场预测（依产品类型、技术、材料、适应症、病患群体和最终用户划分）

Peripheral Vascular Devices Market by Product, Technology Type, Material Type, Indication, Patient Types, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，週边血管医疗设备市场价值将达到 155 亿美元，到 2026 年将成长至 163.9 亿美元，到 2032 年将达到 237.2 亿美元，复合年增长率为 6.26%。

主要市场统计数据
基准年 2025 155亿美元
预计年份：2026年 163.9亿美元
预测年份 2032 237.2亿美元
复合年增长率 (%) 6.26%

重点介绍临床实务、医疗设备创新和医疗保健系统管理的机会和挑战。

週边血管医疗设备市场正处于三大因素的交会点：人口老化、疾病负担的变化、治疗方法的快速发展。临床医生越来越依赖各种医疗设备，从微创导管介入到开放性手术和血管移植。手术方式的多样化推动了对整合式临床路径的需求日益增长，这些路径旨在优化患者预后并控製成本。因此，医院系统和门诊手术中心正在重新审视药品清单、医疗设备采用标准和库存策略，以在常规血管介入治疗中平衡疗效和可重复性。

全面概述将改变週边血管治疗的临床实践、技术应用和竞争格局的变革性变化。

週边血管医疗设备的临床应用格局正经历多重变革，重塑其应用模式与竞争格局。在导管设计、斑块修復技术和支架材料不断改进的推动下，微创技术正持续拓展至以往需要开放性手术治疗的患者族群。这一趋势得益于术中影像和导航技术的进步，这些技术提高了手术精度，并扩大了血管内治疗的适应症。随着临床医生和医疗系统越来越倾向于选择能够缩短恢復时间和住院时间的微创治疗方法，製造商在设计下一代解决方案时，必须优先考虑易用性、与竞争对手产品的兼容性以及已证实的临床疗效。

分析检视美国在 2025 年征收的关税如何影响医疗设备製造商的供应链结构、筹资策略和商业营运。

美国将于2025年实施的关税调整迫使医疗设备製造商和经销商重新评估其全球采购地点和契约製造伙伴关係。虽然关税针对的是特定类别的原材料和成品，但其更广泛的影响正在加速企业对近岸外包机会、双重采购法规以及关键零件生产垂直整合的考虑。製造商越来越重视估算包含关税、运费波动和库存持有成本在内的总到岸成本，并以此作为供应商选择和资本投资决策的依据。因此，医疗设备开发商优先考虑与那些能够提供地理分散、品质稳定且能够根据需求波动柔软性调整生产规模的供应商建立合作关係。

该方法整合了产品分类、程序技术、材料、临床适应症、患者群体和最终用户环境等方面的详细细分见解，以帮助制定有针对性的商业化策略。

产品层面的多样性决定了临床和采购相关人员如何评估週边血管产品线。市场涵盖球囊扩张装置、各种导管、移植物、导管导引线、下腔静脉滤器、导引器、斑块修饰装置、支架和血管闭塞系统。在导管方面，长导管、中线导管和短导管之间的差异会影响手术方案的选择、库存管理以及临床医生培训的重点。移植物的选择取决于材料和生物学因素，生物移植物、可扩张聚四氟乙烯移植物和聚酯移植物各自具有独特的操作特性和长期性能权衡。支架技术进一步分为球囊扩张型和自扩张式，临床医师根据病灶形态、血管大小和输送需求进行选择。

区域洞察揭示了全球主要区域的需求推动要素、法规环境、基础设施能力和战略重点，有助于制定市场进入和扩张计划。

区域趋势对週边血管器械的采纳、报销和临床应用有显着影响。在美洲，成熟的医疗保健体系、完善的报销机制和较高的手术量支持新型微创器械的快速普及；然而，不同的支付模式和医院整合趋势要求采用更为细緻的合约方式。相较之下，欧洲、中东和非洲则呈现出监管差异和基础设施不平衡的复杂局面。欧洲市场倾向于优先考虑严谨的临床证据和集中采购框架，而中东和非洲则可能优先考虑与当地临床专长和供应链限制相契合的技术。这些差异要求企业制定适应性强的打入市场策略和有针对性的证据材料，以满足特定区域的法规和临床需求。

重点分析医疗设备製造商和服务供应商的竞争定位、创新重点领域、伙伴关係趋势和策略挑战等主要企业洞察。

週边血管器械领域的主要企业正透过将器械的渐进式改善与平台层面的创新相结合，从而实现差异化竞争，提高手术效率并改善患者的长期预后。一些企业优先开发模组化系统，以增强与现有导管和影像平台的互通性；而另一些企业则专注于材料科学的突破，旨在优化输送性能并降低再血管再阻塞。随着越来越多的企业致力于提供能够简化临床医生工作流程并支持术中决策的整合式手术解决方案，医疗设备製造商与影像和数位医疗服务提供者之间的策略合作日益普遍。此外，与契约製造和区域生产基地的合作有助于确保供应链的柔软性，并减轻贸易中断的影响。

为帮助行业领导者确定投资优先顺序、协调临床证据策略以及优化供应链韧性以实现永续成长提供实用建议。

首先，优先进行能够同时关注短期手术效果和长期患者终点的临床证据项目。设计可操作的研究和註册登记，使其能够无缝融入常规临床流程，从而加快临床医生接受度，并促进与保险公司的沟通。其次，在开发新型医疗设备时，应注重模组化和互通性，以减少临床医师训练的阻力，并提高其与现有治疗室的整合潜力。第三，提高供应链透明度，并实现采购管道多元化，以最大限度地减少关税相关的成本波动和物流瓶颈的影响。将特定零件外包到近岸地区，并与替代供应商建立合作关係，可以在保持生产连续性的同时优化整体成本。

本报告概述了一种透明的调查方法，解释了支撑本报告见解和建议的证据来源、分析框架和检验程序。

本调查方法结合了对临床、监管和商业领域相关人员的访谈，以及对同行评审文献、监管文件和公开临床註册资料的广泛二次分析。一手研究包括与介入性心臟病专家、血管外科医生、采购经理以及医疗设备製造商和契约製造(CMO) 的高阶主管进行结构化对话，以了解营运限制和策略重点。二次研究整合了医疗设备附加檔、临床试验註册资料、监管指导文件和已发表的疗效研究，从而对性能特征和手术趋势进行多角度检验。

简明扼要的结论，整合了对相关人员的影响，并提出了不断发展的周边血管器械生态系统中的策略重点。

週边血管器械领域正经历手术技术的快速发展、材料的创新以及经济奖励机制的转变，所有这些因素都要求製造商和医疗系统采取灵活且基于循证医学的策略。在许多适应症中，临床路径正朝着微创方向发展，凸显了能够在简化的手术流程中提供稳定性能的器械的重要性。同时，监管机构和支付方的期望进一步加强了上市后监测和基于结果的证据，重申了长期数据收集和价值论证的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 週边血管医疗设备市场：依产品分类

  • 气球膨胀装置
  • 导管
    • 长週边静脉导管
    • 中线导管
    • 短週边静脉导管
  • 接枝
    • 生物移植
    • ePTFE 接枝
    • 聚酯接枝
  • 导管导引线
  • 下腔静脉滤器
  • 导引器
  • 斑块修饰装置
  • 支架
    • 球囊扩张型支架
    • 自动扩张型支架
  • 血管闭合装置

第九章 週边血管医疗设备市场：依技术类型划分

  • 微创手术
    • 血管成形术
    • 支架置入
  • 开放性手术
    • 心臟绕道手术
    • 切除术

第十章 週边血管医疗设备市场：依材料类型划分

  • 金属装置
    • 钴铬合金
    • 镍钛诺
    • 不銹钢
  • 非金属装置
    • 聚合物
    • 硅酮

第十一章 週边血管医疗设备市场：依适应症划分

  • 功能性週边血管疾病
    • 慢性静脉功能不全
    • 雷诺氏症
    • 静脉曲张
  • 阻塞性週边血管疾病
    • 动脉粥状硬化
    • 血栓闭塞性脉管炎
    • 颈动脉疾病
    • 深层静脉栓塞症
    • 淋巴水肿

第十二章 依病患类型分類的周边血管医疗设备市场

  • 成年人和老年人
    • 急性病
    • 慢性病
  • 儿童
    • 后天疾病
    • 先天性疾病

第十三章 週边血管医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十四章 週边血管医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 週边血管医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 週边血管医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国週边血管医疗设备市场

第十八章：中国週边血管医疗设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • ASAHI INTECC CO., LTD
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Kimal PLC
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Sahajanand Medical Technologies Limited
  • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • Siemens Healthineers AG
  • Summa Therapeutics, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market was valued at USD 15.50 billion in 2025 and is projected to grow to USD 16.39 billion in 2026, with a CAGR of 6.26%, reaching USD 23.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.50 billion
Estimated Year [2026] USD 16.39 billion
Forecast Year [2032] USD 23.72 billion
CAGR (%) 6.26%

A focused introduction that frames opportunities and challenges across clinical practice, device innovation, and health systems management

The peripheral vascular devices landscape sits at the intersection of aging demographics, shifting disease burden, and accelerating procedural innovation. Clinicians increasingly rely on a spectrum of devices that span minimally invasive catheter-based therapies to open surgical grafts, and this procedural diversification has elevated the need for integrated clinical pathways that optimize patient outcomes while controlling costs. As a result, hospital systems and ambulatory surgical centers are re-evaluating formularies, device adoption criteria, and inventory strategies to balance efficacy with reproducibility in routine vascular interventions.

Concurrent regulatory evolution is redefining evidence thresholds and post-market surveillance expectations, prompting manufacturers to invest earlier in robust clinical data and to design iterative devices with lifecycle considerations. From a payer perspective, value-based reimbursement constructs and shifting procedure settings are creating new incentives to prioritize devices that demonstrably reduce readmissions, procedural complications, and time to functional recovery. Taken together, these drivers place a premium on cross-disciplinary collaboration among clinical leaders, device developers, and health system purchasers to translate innovation into scalable care delivery improvements.

Looking ahead, companies that harmonize clinical evidence, manufacturing agility, and reimbursement intelligence will capture the strategic advantage required to meet both clinician preferences and institutional procurement standards

A comprehensive view of transformative shifts altering clinical practice, technology adoption, and competitive dynamics across peripheral vascular care

The clinical environment for peripheral vascular devices is undergoing several concurrent shifts that are reshaping adoption patterns and competitive positioning. Minimally invasive techniques continue to expand into patient cohorts previously treated with open surgery, driven by refinements in catheter design, plaque modification technologies, and stent materials. This trend has been enabled by improvements in intraprocedural imaging and navigation, which increase procedural precision and broaden the indications suitable for endovascular approaches. As clinicians and health systems favor less invasive pathways that shorten recovery and reduce hospitalization, manufacturers must emphasize ease-of-use, cross-compatibility, and robust clinical outcomes when designing next-generation solutions.

In parallel, material science advances are prompting renewed attention to long-term biocompatibility and device durability. The shift toward nitinol and cobalt chromium alloys in select classes, along with polymer-based coatings and hybrid materials, reflects a drive to optimize radial strength, deliverability, and endothelialization profiles. Regulatory frameworks and payers are increasingly scrutinizing safety signals and real-world performance, which compels device makers to integrate post-market evidence generation into product strategies. Furthermore, supply chain resilience and localized manufacturing investments are becoming strategic priorities as stakeholders seek to mitigate disruption risks while improving lead times and inventory visibility.

Taken together, these transformative shifts underscore the importance of an evidence-centered commercialization approach that aligns clinical utility with scalable manufacturing and distribution models

An analytical exploration of how the United States tariffs implemented in 2025 are influencing supply chain configurations, sourcing strategies, and commercial operations for device manufacturers

The tariff adjustments introduced in the United States in 2025 have prompted device manufacturers and distributors to reassess global sourcing footprints and contract manufacturing partnerships. While tariffs target specific input categories and finished goods, the broader consequence has been accelerated evaluation of nearshoring opportunities, dual-sourcing provisions, and vertical integration of critical component production. Manufacturers are increasingly modeling total landed costs that account for tariffs, freight volatility, and inventory carrying expenses to inform supplier selection and capital investment decisions. As a result, device developers are prioritizing supplier relationships that offer geographic diversification, quality consistency, and built-in flexibility to scale production in response to demand fluctuations.

Regulatory registration timelines and import compliance considerations are also shaping how firms approach market entry. Companies that rely on multinational supply chains must negotiate additional administrative complexity and potential lead-time extension, particularly for devices with complex multi-component assemblies. Consequently, procurement teams are revisiting contractual terms, adding tariff contingency clauses, and intensifying collaboration with customs and trade compliance experts to preserve margin integrity. For smaller innovators, the tariff environment has increased the comparative attractiveness of licensing agreements or strategic alliances with established manufacturers that already operate compliant, diversified supply chains.

In sum, the 2025 tariff landscape has catalyzed a pragmatic pivot toward resilience and cost transparency, incentivizing investments in supply chain visibility, alternative sourcing, and manufacturing strategies that better absorb trade policy volatility

A detailed synthesis of segmentation insights across product classes, procedural technologies, materials, clinical indications, patient cohorts, and end-user settings to inform targeted commercialization strategies

Product-level heterogeneity defines how clinical and procurement stakeholders evaluate peripheral vascular offerings. The market spans balloon inflation devices, a variety of catheter types, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure systems. Within catheters, distinctions among long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters influence procedural selection, inventory management, and clinician training priorities. Graft choices reflect material and biological considerations, with biological grafts, expanded polytetrafluoroethylene constructions, and polyester grafts each presenting unique handling characteristics and long-term performance trade-offs. Stent technologies further bifurcate into balloon-expandable and self-expanding designs, which clinicians select based on lesion morphology, vessel sizing, and deliverability requirements.

Technology type segmentation contrasts minimally invasive surgeries with open surgical approaches. Minimally invasive pathways, particularly angioplasty and stenting, prioritize device deliverability, imaging compatibility, and adjunctive tools for plaque modification. Conversely, open surgical interventions such as bypass procedures and endarterectomy necessitate robust graft options, perfusion considerations, and specialized instrumentation. Material differentiation between metal devices and non-metal devices drives choices around radial strength, fatigue resistance, and biocompatibility; metal device subtypes include cobalt chromium, nitinol, and stainless steel, while non-metal alternatives encompass polymers and silicone-based solutions with evolving coating technologies.

Clinical indication and patient-type segmentation also shape commercial priorities. Indications span functional peripheral vascular disease-encompassing chronic venous insufficiency, Raynaud's disease, and varicose veins-and occlusive pathology including atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient categories include adult and geriatric cohorts differentiated by acute versus chronic conditions, as well as pediatric populations with acquired or congenital conditions. End-user settings such as ambulatory surgical centers, outpatient clinics, and hospitals each impose different procurement cycles, regulatory oversight, and clinician proficiency expectations. Integrating these segmentation lenses enables companies to align product design, clinical evidence generation, and go-to-market models with the needs of targeted clinical pathways and institutional purchasers

Regional insights that elucidate demand drivers, regulatory environments, infrastructure capacity, and strategic priorities across major global geographies to inform market entry and expansion plans

Regional dynamics materially influence how peripheral vascular devices are adopted, reimbursed, and diffused across care settings. In the Americas, mature healthcare systems, established reimbursement pathways, and high procedure volumes support rapid adoption of novel minimally invasive devices, while divergent payer models and hospital consolidation trends require nuanced contracting approaches. In contrast, Europe, the Middle East and Africa present a mosaic of regulatory heterogeneity and variable infrastructure. European markets often emphasize rigorous clinical evidence and centralized procurement frameworks, whereas Middle Eastern and African markets may prioritize technology that aligns with local clinical expertise and supply chain constraints. These differences necessitate adaptive market access strategies and targeted evidence packages to meet region-specific regulatory and clinical expectations.

The Asia-Pacific region exhibits pronounced heterogeneity in healthcare infrastructure and growth trajectories. Rapid investments in tertiary care centers and increasing procedural capacity in key markets are driving demand for both advanced stent systems and scalable catheter solutions. However, divergent regulatory pathways, local manufacturing incentives, and cost sensitivity require manufacturers to calibrate pricing and localization strategies carefully. Across all regions, health system priorities such as reducing hospital length of stay, improving procedural throughput, and minimizing complication rates serve as universal levers that device developers can address through evidence-based product claims and tailored clinical support programs. Ultimately, a differentiated regional approach that combines rigorous clinical data, regulatory expertise, and operational partnerships will be essential to achieving sustainable adoption across these geographies

Key company insights highlighting competitive positioning, innovation focus areas, partnership dynamics, and strategic imperatives for device manufacturers and service providers

Leading companies in the peripheral vascular device domain are differentiating through a combination of incremental device improvements and platform-level innovations that address procedural efficiency and long-term patient outcomes. Some firms are prioritizing modular systems that enhance cross-compatibility with existing catheter and imaging platforms, whereas others concentrate on material science breakthroughs to optimize deliverability and reduce restenosis. Strategic alliances between device manufacturers and imaging or digital health providers are becoming more common as companies seek to deliver integrated procedural solutions that streamline clinician workflows and support intraoperative decision-making. In addition, partnerships with contract manufacturers and localized production hubs help secure supply chain flexibility and reduce exposure to trade-related disruptions.

Competitive differentiation also hinges on how companies approach clinical evidence and reimbursement support. Firms that invest in pragmatic trial designs, registry partnerships, and health economics dossiers are better positioned to demonstrate value to payers and institutional buyers. For innovators and smaller entrants, licensing agreements, co-development alliances, and targeted collaborations with health systems provide pathways to scale while sharing development risk. Across the competitive landscape, successful players balance near-term commercial execution with longer-term investments in product portfolios that anticipate shifts in clinical practice and regulatory expectations

Actionable recommendations that equip industry leaders to prioritize investments, align clinical evidence strategies, and optimize supply chain resilience for sustained growth

First, prioritize clinical evidence programs that address both short-term procedural outcomes and longer-term patient-centric endpoints. Designing pragmatic studies and registries that integrate seamlessly with routine care pathways will accelerate clinician acceptance and support payer conversations. Second, invest in modularity and interoperability when developing new devices to reduce clinician training friction and increase the likelihood of integration into existing procedural suites. Third, strengthen supply chain visibility and diversify sourcing to minimize exposure to tariff-driven cost fluctuations and logistical bottlenecks. Nearshoring certain components and cultivating redundant supplier relationships can preserve production continuity while optimizing landed costs.

Fourth, tailor market access strategies to regional regulatory and reimbursement nuances, ensuring that localized evidence packages and pricing frameworks reflect clinical priorities and payer thresholds. Fifth, develop clinician-facing value propositions that extend beyond device performance to include training, procedural support, and outcomes-tracking capabilities. Finally, pursue strategic partnerships with imaging and digital health providers to enhance intraoperative decision-making and to generate real-world evidence that supports adoption and reimbursement. By combining evidence-led commercialization with operational resilience and collaborative partnerships, industry leaders can better navigate market complexity and drive sustained clinical and commercial impact

A transparent research methodology explaining the evidence sources, analytic frameworks, and validation steps that underpin the insights and recommendations in the report

The research methodology combines primary interviews with clinical, regulatory, and commercial stakeholders and extensive secondary analysis of peer-reviewed literature, regulatory filings, and publicly available clinical registries. Primary engagements include structured conversations with interventional cardiologists, vascular surgeons, procurement leaders, and senior executives from device firms and contract manufacturers to capture real-world operational constraints and strategic priorities. Secondary research synthesizes device labeling, clinical trial registries, regulatory guidance documents, and published outcomes studies to triangulate performance characteristics and procedural trends.

Analytic frameworks incorporate segmentation analysis across device class, technology type, material composition, clinical indication, patient demographics, and care setting. These frameworks drive cross-sectional comparisons and enable identification of value drivers that influence adoption. Validation steps include cross-referencing primary interview findings with secondary evidence, performing sensitivity checks on thematic conclusions, and conducting peer reviews with clinical experts to ensure the accuracy and relevance of clinical assertions. This rigorous approach ensures that recommendations are grounded in multiple evidence streams and reflect the practical considerations that shape decision-making across clinical and commercial audiences

A concise conclusion that synthesizes implications for stakeholders and frames strategic priorities for the evolving peripheral vascular device ecosystem

The peripheral vascular device environment is characterized by rapid procedural evolution, material innovation, and shifting economic incentives that collectively demand agile, evidence-centered strategies from manufacturers and health systems alike. Clinical pathways are trending toward less invasive approaches in many indications, which places a premium on devices that deliver consistent performance with streamlined procedural workflows. Simultaneously, regulatory and payer expectations are driving deeper commitments to post-market surveillance and outcomes-based evidence, reinforcing the importance of long-term data collection and value demonstration.

To succeed, stakeholders must harmonize device innovation with pragmatic clinical evidence and resilient operational models. This entails investing in interoperable technologies, targeting regionally tailored market access plans, and fortifying supply chains to withstand policy and logistical shocks. Ultimately, companies that can translate clinical differentiation into clear value for clinicians, patients, and payers will be best positioned to capture adoption in a complex and rapidly changing landscape. These strategic priorities should guide near-term tactical decisions and longer-term portfolio investments as the industry moves forward

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Devices Market, by Product

  • 8.1. Balloon Inflation Devices
  • 8.2. Catheters
    • 8.2.1. Long Peripheral Intravenous Catheters
    • 8.2.2. Midline Catheters
    • 8.2.3. Short Peripheral Intravenous Catheter
  • 8.3. Grafts
    • 8.3.1. Biological Grafts
    • 8.3.2. ePTFE Grafts
    • 8.3.3. Polyester Grafts
  • 8.4. Guidewires
  • 8.5. Inferior Vena Cava Filters
  • 8.6. Introducers
  • 8.7. Plaque Modification Devices
  • 8.8. Stents
    • 8.8.1. Balloon-Expandable Stents
    • 8.8.2. Self-Expanding Stents
  • 8.9. Vascular Closure Devices

9. Peripheral Vascular Devices Market, by Technology Type

  • 9.1. Minimally Invasive Surgeries
    • 9.1.1. Angioplasty
    • 9.1.2. Stenting
  • 9.2. Open Surgery
    • 9.2.1. Bypass Surgery
    • 9.2.2. Endarterectomy

10. Peripheral Vascular Devices Market, by Material Type

  • 10.1. Metal Devices
    • 10.1.1. Cobalt Chromium
    • 10.1.2. Nitinol
    • 10.1.3. Stainless Steel
  • 10.2. Non-Metal Devices
    • 10.2.1. Polymer
    • 10.2.2. Silicone

11. Peripheral Vascular Devices Market, by Indication

  • 11.1. Functional Peripheral Vascular Disease
    • 11.1.1. Chronic Venous Insufficiency
    • 11.1.2. Raynaud's Disease
    • 11.1.3. Varicose Veins
  • 11.2. Occlusive Peripheral Vascular Disease
    • 11.2.1. Atherosclerosis
    • 11.2.2. Buerger's Disease
    • 11.2.3. Carotid Artery Disease
    • 11.2.4. Deep Vein Thrombosis
    • 11.2.5. Lymphedema

12. Peripheral Vascular Devices Market, by Patient Types

  • 12.1. Adult & Geriatric
    • 12.1.1. Acute Conditions
    • 12.1.2. Chronic Conditions
  • 12.2. Pediatric
    • 12.2.1. Acquired Conditions
    • 12.2.2. Congenital Conditions

13. Peripheral Vascular Devices Market, by End-User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Peripheral Vascular Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Vascular Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Vascular Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Peripheral Vascular Devices Market

18. China Peripheral Vascular Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AngioDynamics, Inc.
  • 19.7. Argon Medical Devices, Inc.
  • 19.8. ASAHI INTECC CO., LTD
  • 19.9. B. Braun SE
  • 19.10. Baxter International Inc.
  • 19.11. Becton, Dickinson and Company
  • 19.12. BIOTRONIK SE & Co. KG
  • 19.13. Boston Scientific Corporation
  • 19.14. Cardinal Health, Inc.
  • 19.15. Cook Group Incorporated
  • 19.16. Esaote S.p.A.
  • 19.17. FUJIFILM Holdings Corporation
  • 19.18. GE HealthCare
  • 19.19. Kimal PLC
  • 19.20. Koninklijke Philips N.V.
  • 19.21. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.22. Medtronic PLC
  • 19.23. Merit Medical Systems, Inc.
  • 19.24. Nipro Corporation
  • 19.25. Penumbra, Inc.
  • 19.26. Sahajanand Medical Technologies Limited
  • 19.27. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • 19.28. Siemens Healthineers AG
  • 19.29. Summa Therapeutics, LLC
  • 19.30. Teleflex Incorporated
  • 19.31. Terumo Corporation
  • 19.32. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)